Home/Filings/4/0000899243-20-019856
4//SEC Filing

Frail Donald 4

Accession 0000899243-20-019856

CIK 0001807901other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 7:29 PM ET

Size

14.1 KB

Accession

0000899243-20-019856

Insider Transaction Report

Form 4
Period: 2020-07-17
Frail Donald
Director
Transactions
  • Conversion

    Common Stock

    2020-07-21+11,74151,113 total
  • Purchase

    Common Stock

    2020-07-21$18.00/sh+10,000$180,00061,113 total
  • Award

    Stock Option (right to buy)

    2020-07-17+4,7504,750 total
    Exercise: $18.00Exp: 2030-07-16Common Stock (4,750 underlying)
  • Award

    Stock Option (right to buy)

    2020-07-17+13,99713,997 total
    Exercise: $18.00Exp: 2030-07-16Common Stock (13,997 underlying)
  • Conversion

    Series B Preferred Stock

    2020-07-2159,8720 total
    Common Stock (11,741 underlying)
Footnotes (4)
  • [F1]The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
  • [F3]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on September 27, 2020, with the remainder of the shares vesting in equal monthly installments following September 27, 2020 through September 27, 2023, subject to the reporting person's continued service on each applicable vesting date.
  • [F4]This option award was granted on July 17, 2020. The shares underlying the award vest in equal monthly installments following July 17, 2020 through July 17, 2023, subject to the reporting person's continued service on each applicable vesting date.

Issuer

Pandion Therapeutics, Inc.

CIK 0001807901

Entity typeother

Related Parties

1
  • filerCIK 0001817514

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:29 PM ET
Size
14.1 KB